Cargando…
Cancer therapy and cardiovascular risk: focus on bevacizumab
Recognition and management of treatment-related cardiovascular toxicity, defined as either an acute cardiac event or a chronic condition, has been tightly integrated into routine cancer care and has become an important component in treatment selection. Several chemotherapeutic agents, such as anthra...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461138/ https://www.ncbi.nlm.nih.gov/pubmed/26082660 http://dx.doi.org/10.2147/CMAR.S77400 |